Promising Nanotechnology Stocks To Add to Your Watchlist - April 21st

Key Points

• MarketBeat's screener flagged Onto Innovation (ONTO), NVE (NVEC), Nano Dimension (NNDM) and Clene (CLNN) as nanotechnology stocks to watch based on the highest recent dollar trading volume; nanotech offers exposure to an emerging, potentially high-growth sector but typically carries higher technical, regulatory and market risk.
• Company focuses: Onto Innovation supplies optical metrology and lithography process-control tools for semiconductor manufacturing; NVE develops spintronic sensors and couplers; Nano Dimension makes additive-manufacturing/3D-printing systems for electronic, polymer, ceramic and metal parts; Clene is a clinical-stage biopharma developing the nanotech therapeutic CNM-Au8 with multiple Phase 2 trials in neurodegenerative diseases.

Onto Innovation, NVE, Nano Dimension, and Clene are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies whose core business involves the research, development, manufacture, or commercialization of nanoscale materials, devices, tools, or processes — including instrument makers, material suppliers, and firms applying nanotech in products. For investors, these equities offer exposure to an emerging, potentially high-growth technology sector but typically carry higher technical, regulatory and market risk and can be more speculative than established industries. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

Onto Innovation (ONTO)

Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements.

Read Our Latest Research Report on ONTO

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

Read Our Latest Research Report on NVEC

Nano Dimension (NNDM)

Nano Dimension Ltd., together with its subsidiaries, engages in additive manufacturing solutions in Israel and internationally. The company offers 3D printers, comprising AME systems, which are inkjet printers, that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; micro additive manufacturing systems, a digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and industrial additive manufacturing systems, that utilizes a patented foil system that fabricates ceramic and metal parts.

Read Our Latest Research Report on NNDM

Clene (CLNN)

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.

Read Our Latest Research Report on CLNN

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.